Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial-Reference-Cited by-同舟云学术

Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

Published:2020-09 Issue:9 Volume:19 Page:727-737
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Goadsby Peter J,Dodick David W,Ailani Jessica,Trugman Joel M,Finnegan Michelle,Lu Kaifeng,Szegedi Armin

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference28 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Vos;Lancet,2017

2. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study;Buse;Headache,2012

3. Lost productive time and cost due to common pain conditions in the US workforce;Stewart;JAMA,2003

4. The economic cost of brain disorders in Europe;Olesen;Eur J Neurol,2012

5. Pathophysiology of migraine: a disorder of sensory processing;Goadsby;Physiol Rev,2017

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events associated with Atogepant: a FAERS-based pharmacovigilance analysis;Expert Opinion on Drug Safety;2024-09-12

2. Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine;Expert Review of Neurotherapeutics;2024-09-12

3. Causality between migraine and cardiovascular disease: a bidirectional Mendelian randomization study;The Journal of Headache and Pain;2024-08-13

4. Evidence‐based review and frontiers of migraine therapy;Neurogastroenterology & Motility;2024-08-12

5. Efficacy and safety of atogepant, a small molecule CGRP receptor antagonist, for the preventive treatment of migraine: a systematic review and meta-analysis;The Journal of Headache and Pain;2024-07-19